Interactions between 2-(2,6-dichlorophenylamino)-2-imidazoline hydrochloride (St 155, Catapresan®) and α-adrenergic blocking drugs
- 1 January 1970
- journal article
- Published by Elsevier in European Journal of Pharmacology
- Vol. 9 (1) , 7-13
- https://doi.org/10.1016/0014-2999(70)90313-4
Abstract
No abstract availableKeywords
This publication has 9 references indexed in Scilit:
- Effect of intraventricular phentolamine on hyper- and hypotensive vasomotor reflexesEuropean Journal of Pharmacology, 1968
- Analysis of the cardiovascular effects of 2-(2,6-dichlorophenylamino)-2-imidazoline hydrochloride (Catapres)European Journal of Pharmacology, 1968
- Cardiovascular effects of 2-(2,6-dichlorophenylamino)-2-imidazoline hydrochloride (ST 115)European Journal of Pharmacology, 1968
- Cardiovascular effects of 2-(2,6-dichlorophenylamino)-2-imidazoline hydrochloride (ST 155)European Journal of Pharmacology, 1968
- Evidence for a central hypotensive mechanism of 2-(2,6-dichlorophenylamino)-2-imidazoline (catapresan, ST-155)European Journal of Pharmacology, 1968
- Investigations into the mechanism of the hypotensive effect of 2-(2,6-dichlorphenylamino)-2-imidazoline-HClEuropean Journal of Pharmacology, 1967
- Centrally mediated decrease in sympathetic tone induced by 2(2,6-dichlorophenylamino)-2 imidazoline (S.T. 155, Catapresan)European Journal of Pharmacology, 1967
- Acute hypotensive action of 2-(2,6-dichlorophenylamino)- 2-imidazoline hydrochloride (St 155) after infusion into the cat's vertebral arteryEuropean Journal of Pharmacology, 1967
- ber den Wirkungsmechanismus einer neuen antihypertensiven Substanz mit ImidazolinstrukturNaunyn-Schmiedebergs Archiv für experimentelle Pathologie und Pharmakologie, 1967